Criminal!!!

Who is the Bernie Madoff of Vaccines?

By Kim Stagliano

Vaccines are the new black. No, that's not right. Wait, let me think. Vaccines are the new green. There. That's better! Bloomberg (the business folks) reports candidly how vaccines have become "blockbusters" and provide a steady source of income not dependent on patent protection and the perfect customer known as "the government." Boy, get your AAP to pop a new vax onto the pediatric schedule and you're golden! So are your pockets. “Who would have thought that vaccines would be blockbusters?” Poussot asked at an investor meeting in New York yesterday before the deal was reported. “Five years ago, nobody believed that a vaccine could ever do that, but we have been able to do that with Prevnar.” Vaccines make money. A lot of it. Don't think for a second that the Paul Offit's of the world are solely interested in your health. Money = corruption. Bernie Madoff ring a bell?

From Bloomberg HERE.

...Wyeth Chief Executive Officer Bernard Poussot has focused the company’s research on vaccines, a dependable source of sales for drugmakers because they don’t lose patent protection and are often purchased by governments. Poussot turned Wyeth’s pneumonia vaccine Prevnar into its second best-selling product with $2.4 billion in 2007 revenue.



‘Blockbuster’ Vaccines

Wyeth and rival drugmakers are looking for acquisitions as $84 billion worth of their prescription products are scheduled to lose patent protection by 2013. Wyeth is the world’s fourth- richest drugmaker, with $14.1 billion in cash and short-term assets as of Sept. 30, according to data complied by Bloomberg.

Wyeth’s top-selling Effexor depression pill, with $3.8 billion in 2007 sales, will get generic competition next year. The company is trying to reduce its dependence on pharmaceuticals and plans to reap 75 percent of its revenue by 2012 from biotechnology medicines, vaccines, over-the-counter treatments and animal products, Poussot has said.

Kim Stagliano is Managing Editor of Age of Autism.